RetroBiosciences and OpenAI used a new biology LLM, GPT-4b micro, to re-engineer Yamanaka factors — proteins that reset cells to a younger state.
- The AI-designed versions boosted reprogramming efficiency 50x in lab tests
- Past factors were too weak and risky for safe therapies — these new ones look far more practical
- Could enable controlled rejuvenation of human cells, opening the door to anti-aging treatments
Most people still underestimate how fast AI may crack the biology of aging.